Abivax fell by 1.2% to 8.78 euros on Friday, while the group’s operating profit stood at -18.6 million euros at June 30, 2022 (-1.7 million euros compared to -16 .9 million euros recognized as of June 30, 2021), with a decrease in ‘R&D’ expenses in the first half of 2022 compared…
©2022 Boursier.com